Healthcare
Topics also related to Healthcare:
Merck's Keytruda fails late-stage study in liver cancer patients
Feb 19 Merck & Co Inc said on Tuesday its cancer drug Keytruda failed the main goals of a late-stage trial and did not extend life of patients with a type of liver cancer.
UPDATE 3-Allergan should explore selling itself - Appaloosa's Tepper
Feb 19 Billionaire hedge fund manager David Tepper stepped up pressure on Allergan Plc, saying on Tuesday the drugmaker should consider selling itself if management is unable to turn around recent lagging performance.
UPDATE 1-Honeywell-Pratt venture protests GE's Army helicopter contract
Feb 19 A joint venture of Honeywell International Inc and Pratt & Whitney on Tuesday protested the U.S. Army's decision to award General Electric Co a $517 million contract for new Black Hawk and Apache helicopter engines.
Honeywell-Pratt venture protests U.S. Army's contract to GE
Feb 19 A joint venture of Honeywell International Inc and Pratt & Whitney on Tuesday protested the U.S. Army's decision to award General Electric Co a contract for new Black Hawk and Apache helicopter engines.
UPDATE 1-U.S. top court rejects bid to block Indivior opioid drug copycat
WASHINGTON, Feb 19 The U.S. Supreme Court dealt a blow to Indivior Plc on Tuesday, clearing the way for a copycat version of the British pharmaceutical firm's lucrative opioid addiction treatment Suboxone Film in a victory for India-based generic drug maker Dr. Reddy's Laboratories .
| Healthcare | ||
| Johnson & Johnson | $135.69 | -0.51% |
| UnitedHealth Group Inc | $270.41 | -0.27% |
| Pfizer Inc | $42.60 | +0.47% |
Markets
- U.S.
- Europe
- Asia
- Sectors
| DOW | 25,891.32 |
+
8.07 |
+0.03% |
| S&P 500 | 2,779.76 |
+
4.16 |
+0.15% |
| NASDAQ | 7,486.77 |
+
14.36 |
+0.19% |
| TR US Index | 247.04 |
+
0.41 |
+0.17% |
Sector Summary
| Energy |
+0.53%
|
| Basic Materials |
+0.85%
|
| Industrials |
+0.14%
|
| Cyclical Goods & Services |
+0.34%
|
| Non-Cyclical Goods & Services |
+0.36%
|
| Financials |
+0.23%
|
| Healthcare |
-0.26%
|
| Technology |
+0.12%
|
| Telecoms |
+0.32%
|
| Utilities |
+0.60%
|
Upcoming Events
No related earnings announcements are currently scheduled within the next 7 days.